According to WHO, Pharmacovigilance (PV) is defined as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem.

At the end of May 2016, 153 countries were part of the WHO PV Program.

Objective of PV:

Patient Care: To improve patient care & safety
Public Health: Early detection of unknown safety problem
Risk Benefit Assessment: To contribute to the identification, assessment of benefit, harm, effectiveness & risk of medicine.

Biocyte Healthcare Ltd is committed to inculcating Good PV Practices to improve patient care & safety by the rational & safe use of our products to create awareness regarding PV.

Our Pharmacovigilance activities are carried out by a group of qualified pharmacists.

What to Report

All serious & non-serious adverse events (AE) or adverse drug reactions (ADR) have to be

reported to the Pharmacovigilance team.

How to Report

Any adverse event regarding Biocyte Healthcare Ltd products can be reported by

Phone call or SMS to the PV team or filling up Adverse Events (AE) Form and sending it through Email

Minimum Information for Reporting

An adverse event report should contain four essential information

1. Patient’s Details

Name/Initials
Gender, Age
Contact number
Pregnancy status

2. Reporter’s Details

Name
Occupation
Address
Contact number

3. Adverse Event

Date of onset
Symptoms
Outcome
Seriousness
Medical history

4. Suspected Product(s)

Brand name
Dose, frequency
Route
Batch number
Other medication